White matter integrity and cognition in Parkinson's disease: A cross-sectional study

BMJ Open

Volumn 4, Issue 1, 2014, Pages

  Auning, Eirik ^a,b   Kjærvik, Veslemøy Krohn ^a   Selnes, Per ^a   Aarsland, Dag ^a,c,d   Haram, Astrid ^b,e   Bjørnerud, Atle ^b,f   Hessen, Erik ^a,b   Esnaashari, Abdolreza ^a   Fladby, Tormod ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d STAVANGER UNIVERSITY HOSPITAL   (Norway)

^e Ostfold Central Hospital   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIFFUSION TENSOR IMAGING; ENTORHINAL CORTEX; EXECUTIVE FUNCTION; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; PARIETAL CORTEX; PARKINSON DISEASE; PREFRONTAL CORTEX; PSYCHOLOGIC TEST; TEMPORAL CORTEX; WHITE MATTER; WHITE MATTER INTEGRITY; COGNITION DISORDERS; COMPLICATION; PATHOLOGY;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; WHITE MATTER;

EID: 84892887486     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003976     Document Type: Article

References (43)

1. Svenningsson P, Westman E, Ballard C, et al. Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment. [Review]. Lancet Neurol 2012;11:697-707.
2. Bohnen NI, Albin RL. White matter lesions in Parkinson disease. [Review]. Nat Rev Neurosci 2011;7:229-36.
3. Kamagata K, Motoi Y, Abe O, et al. White matter alteration of the cingulum in Parkinson disease with and without dementia: evaluation by diffusion tensor tract-specific analysis. AJNR Am J Neuroradiol 2012;33:890-5.
4. Hattori T, Orimo S, Aoki S, et al. Cognitive status correlates with white matter alteration in Parkinson's disease. Hum Brain Mapp 2012;33:727-39.
5. Selnes P, Aarsland P, Bjørnerud A, et al. Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial lobe atrophy in subjective cognitive impairment and mild cognitive impairment. J Alzheimer Dis 2013;33:723-36.
6. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. [Review] [71 refs]. Arch Neurol 1999;56:33-9. (Pubitemid 29046907)
7. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. [Review] [143 refs]. Lancet Neurol 2007;6:734-46. (Pubitemid 47058377)
8. Fjell AM, Walhovd KB, Amlien I, et al. Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment. AJNR Am J Neuroradiol 2008;29:1183-9. (Pubitemid 351954891)
9. Sjogren M, Vanderstichele H, Agren H, et al. Tau and A beta 42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 2001;47:1776-81. (Pubitemid 32881189)
10. Darcourt J, Booij J, Tatsch K, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 2010;37:443-50.
11. Fahn S, Elton R. Members of the UPDRS development committee: Unified Parkinson's Disease Rating Scale. In Fahn S, Marsden CD, Calne DB Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park: MacMillan Health Care Information, 1987:153-63.
12. Hoehn MH, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
13. Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. [Review]. Mov Disord 2010;25:2649-53.
14. Almeida OP, Almeida SA. Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 1999;14:858-65. (Pubitemid 29495547)
15. Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-6. (Pubitemid 17104996)
16. Auer S, Reisberg B. The GDS/FAST staging system. Int Psychogeriatr 1997;9(1 Suppl):167-71. (Pubitemid 28045356)
17. Watson GS, Leverenz JB. Profile of cognitive impairment in Parkinson's disease. [Review] [58 refs]. Brain Pathol 2010;20:640-5.
18. Schmidt M. Rey auditory and verbal learning test. A handbook. Los Angeles, CA: Western Psychological Services, 1996.
19. Meyers Je, Meyers JR. Rey complex figure test and recognition trail. Lutz, FL: Psychological Assessment Resources, 1995.
20. Spreen O, Strauss EA. A compendium of neuropsychological tests, second edition: administrations, norms and commentary. New York: Oxford University Press, 1998.
21. Delis DC, Kaplan E, Kramer JH. Delis and Kaplan executive functions system: examiner's manual. San Antonio, TX: The Psychological Corporation, 2001.
22. Heaton RK, Miller SW, Taylor MJ, et al. Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, 2004.
23. Boller F, Passafiume D, Keefe NC, et al. Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. Arch Neurol 1984;41:485-90. (Pubitemid 14133537)
24. Pirozzolo FJ, Hansch EC, Mortimer JA, et al. Dementia in Parkinson disease: a neuropsychological analysis. Brain Cogn 1982;1:71-83.
25. Mosimann UP, Mather G, Wesnes KA, et al. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 2004;63:2091-6. (Pubitemid 39636257)
26. Watson GS, Leverenz JB. Profile of cognitive impairment in Parkinson's disease. [Review] [58 refs]. Brain Pathol 2010; 20:640-5.
27. Abe Y, Kachi T, Kato T, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003;74:419-22. (Pubitemid 36379360)
28. Colloby SJ, Fenwick JD, Williams ED, et al. A comparison of (99 m) Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging 2002;29:615-22. (Pubitemid 34439321)
29. Ungerleider LG, Haxby JV. 'What' and 'where' in the human brain. [Review] [86 refs]. Curr Opin Neurobiol 1994;4:157-65.
30. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. [Review] [93 refs]. Mov Disord 2005;20:130-40. (Pubitemid 40361115)
31. Alvarez JA, Emory E. Executive function and the frontal lobes: a meta-analytic review. [Review] [199 refs]. Neuropsychol Rev 2006;16:17-42. (Pubitemid 43954075)
32. Cummings JL. Frontal-subcortical circuits and human behavior. [Review] [71 refs]. Arch Neurol 1993;50:873-80. (Pubitemid 23229317)
33. Woolrich MW, Jbabdi S, Patenaude B, et al. Bayesian analysis of neuroimaging data in FSL. Neuroimage 2009;45(1 Suppl): S173-86.
34. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487-505.
35. Rueckert D, Sonoda LI, Hayes C, et al. Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 1999;18:712-21. (Pubitemid 32262025)
36. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341-55. (Pubitemid 34162530)
37. Fischl B, van der Kouwe A, Destrieux C, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004;14:11-22. (Pubitemid 38018050)
38. Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006; 31:968-80. (Pubitemid 44183792)
39. Zhan W, Kang GA, Glass GA, et al. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord 2012;27:90-7.
40. Watson R, Blamire AM, Colloby SJ, et al. Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology 2012;79:906-14.
41. Kamagata K, Motoi Y, Tomiyama H, et al. Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis. Eur Radiol 2013;23:1946-55.
42. Meltzer TR, Watts R, MacAskill MR, et al. White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurology 2013;80:1841-9.
43. Agosta F, Canu E, Stefanova E, et al. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage. Hum Brain Mapp 2013. doi: 10.1002/hbm. 22302. [Epub ahead of print].